• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101967-950
Device Problem Imprecision (1307)
Patient Problem Hyperglycemia (1905)
Event Date 06/25/2023
Event Type  Injury  
Event Description
Senseonics was made aware of an incident where the customer experienced a false hyperglycemia event on (b)(6) 2023 at 01:07 pm.The customer reported that sensor glucose (sg) was 20,1 mmol/dl where as the measured blood glucose (bg) value was 8,3 mmol/dl.The customer complained of receiving a high glucose alert when there was no such symptoms and the measured bg value was in normal glucose range.The customer did not have to take any action because there were no symptoms.
 
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The initial investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the initial investigation analysis, the customer reported false hyperglycemia event on (b)(6) 2023 at the time of event was confirmed.A diagnostic upload was requested from the customer to do further investigation, and it indicated that the sensor performance had deviated from the normal behavior due to noise in sensor readings.A sensor replacement alert was also triggered at the time by the system when its diagnostics determined that sensor performance is not acceptable to be providing glucose values.To further investigate the issue and to determine the root cause, a return material authorization (rma) was issued for the return and replacement of sensor.The investigation of the returned sensor, however, did not reveal any malfunction.This may occur in instances where the failure mode that presents itself in the body cannot be reproduced in the lab.The customer had reported that there was infection at the insertion site, which could potentially be the root cause of the in-vivo glucose reading noise leading to the performance failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117359
MDR Text Key327880175
Report Number3009862700-2023-00275
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/12/2023
Device Model Number101967-950
Device Catalogue NumberFG-4500-50-302
Device Lot NumberWP09082
Was Device Available for Evaluation? Yes
Date Manufacturer Received09/25/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-